Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune and inflammatory signaling networks are complex systems of molecular interactions that coordinate the body's response to pathogens and tissue damage (Nature Reviews Immunology, 2017). These networks involve various components, including cell-surface receptors like Toll-like receptors (TLRs), intracellular signaling molecules such as Janus kinases (JAKs), and transcription factors like NF-κB (NIH, 2023). Their primary biological function is to maintain homeostasis by initiating and resolving inflammatory responses (PubMed, 2022). However, dysregulation of these networks is central to the pathogenesis of autoimmune diseases, chronic inflammation, and cancer (StatPearls, 2023). While many drugs target specific nodes within these networks—such as TNF inhibitors or JAK inhibitors—the networks themselves are too broad to be considered a single therapeutic target. Therefore, this entry represents a high-level biological category rather than a specific, druggable molecule.
Inhibition of specific signaling nodes (e.g., cytokines, kinases) to modulate the broader immune and inflammatory response.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune and inflammatory signaling networks.